Some of technology's greatest advances in the last century have come in the world of biology and specifically, synthetic and systems biology. The advent of rapid, low-cost sequencing and gene synthesis allows scientists and engineers to come together and tackle problems that have never before been addressed. Novophage is unlocking the power of biology for the mainstream industrial sector, leveraging these biomedical technological advances. Synthetic biology holds the key for creating effective solutions to industrial process problems that are difficult to address with current solutions, while also reducing the necessity for chemicals and expensive equipment.

Novophage has developed a series of proprietary models based on sampling a variety of industrial systems, referred to as our "Industrial Genome Project." By gaining a better understanding of the microbes that inhabit various industrial systems, we can create targeted solutions to solve problems related to energy loss, corrosion and product or system fouling.

Our core technology leverages nature's most abundant biological particles, "phages" to functionalize and thereby turn bacteria into "in situ factories." The technology is based on a patent pending approach that couples enzymes that are specifically optimized for a particular application and delivered to the site by the phages.